Long Acting Injectable Antipsychotics: Ongoing use during the COVID-19 pandemic and successful use of internet-based support in Greece
- 1 July 2021
- journal article
- letter
- Published by Elsevier in The European Journal of Psychiatry
- Vol. 35 (3) , 204-205
Abstract
No abstract availableThis publication has 5 references indexed in Scilit:
- Long acting injectable antipsychotic medications: Ensuring care continuity during the COVID-19 pandemic restrictionsSchizophrenia Research, 2020
- Long-acting injectable antipsychotics treatment during COVID-19 pandemic – A new challengeSchizophrenia Research, 2020
- Decision-making Capacity for Treatment of Psychotic Patients on Long Acting Injectable Antipsychotic TreatmentArchives of Psychiatric Nursing, 2018
- Nonadherence with antipsychotic medication in schizophrenia: challenges and management strategiesPatient Related Outcome Measures, 2014
- Health professionals' attitudes to depot injection antipsychotic medication: a systematic reviewJournal of Psychiatric and Mental Health Nursing, 2010